- $466.48m
- $431.92m
- $139.88m
- 82
- 32
- 89
- 75
Annual balance sheet for Innovid, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 11.6 | 15.6 | 157 | 47.5 | 49.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 26.4 | 34.8 | 35.4 | 43.7 | 46.4 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 39.7 | 51.6 | 195 | 93.8 | 102 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.9 | 2.33 | 4.84 | 17.2 | 19.9 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 47.2 | 59.5 | 206 | 260 | 250 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.64 | 11 | 21.9 | 21.2 | 25.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.3 | 22.2 | 44.3 | 53.7 | 54 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 36.9 | 37.3 | 161 | 206 | 196 |
| Total Liabilities & Shareholders' Equity | 47.2 | 59.5 | 206 | 260 | 250 |
| Total Common Shares Outstanding |